Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.0%

1 terminated out of 20 trials

Success Rate

92.9%

+6.4% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

15%

2 of 13 completed with results

Key Signals

2 with results93% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (1)
P 1 (2)
P 4 (1)

Trial Status

Completed13
Unknown6
Terminated1

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT02751762Completed

A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain

NCT03422211Completed

A Prospective Assessment of Opioid Utilization Post-operatively in Sports Orthopaedic Surgeries

NCT02660619Completed

Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication

NCT02667262Completed

An Observational Study to Develop Algorithms for Identifying Opioid Abuse and Addiction Based on Admin Claims Data

NCT02667210Completed

Study to Eval Relation Btw Doctor/Pharmacy Shopping & Outcomes of Misuse, Diversion, Abuse, Addiction by Med Rec Review

NCT02667197Completed

Study to Validate Coded Medical Terms Used to Identify Opioid-Related Overdose in Databases Used for PMR Study 1B

NCT02678507Completed

A Quantitative Study to Assess the Construct Validity of the Prescription Opioid Misuse and Abuse Questionnaire

NCT02660606Completed

A Qualitative Study to Assess the Content Validity of the Prescription Opioid Misuse and Abuse Questionnaire

NCT02668549Completed

Cross-Sectional Study to Define and Validate "Doctor/Pharmacy Shopping" as Outcomes Suggestive of Abuse and/or Addiction

NCT02667158Completed

A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or Diversion

NCT02741076Phase 4Terminated

Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain

NCT00999544Not ApplicableCompletedPrimary

Aprepitant Effects on Oxycodone Response

NCT02925806Unknown

Evaluation of Drug Utilization Patterns for Extended Release/Long Acting Opioids and Comparator Products

NCT02866266Unknown

ER/LA Opioid Surveillance for Emergency Department Visits and Hospitalizations for Overdose and Poisoning

NCT02920775Unknown

Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid Analgesics

NCT02920762Unknown

Evaluation of Changes in Prescribing Behavior of ER/LA Opioid Prescribers

NCT02897414Unknown

ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner Databases

NCT02871232Unknown

Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers

NCT01595867Phase 1CompletedPrimary

Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo

NCT01530542Phase 1Completed

A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Volunteers

Showing all 20 trials

Research Network

Activity Timeline